Recap: ADMA Biologics Q1 Earnings
ADMA Biologics (NASDAQ:ADMA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
ADMA Biologics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.
Revenue was up $13.05 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 8.67% increase in the share price the next day.
Here's a look at ADMA Biologics's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for ADMA Biologics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.